4th Quarter - Report

ENDO INTERNATIONAL for ENDO INTERNATIONAL

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 20, 2023 $140,000 Replaced
4th Quarter - Amendment (No Activity) Jul 19, 2023 $140,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Medicare reimbursement of pharmaceuticals and the Inflation Reduction Act; Issues related to FDA policy; Issues related to implementation of the Bipartisan Infrastructure Law

LobbyistCovered position, as disclosed
JAMES MANSER New —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.